{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T19:19:45Z","timestamp":1777663185396,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["No. 2023JJ40971"],"award-info":[{"award-number":["No. 2023JJ40971"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["No. 2023JJ30965"],"award-info":[{"award-number":["No. 2023JJ30965"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92518-3","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T16:18:17Z","timestamp":1741018697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiparameter diagnostic model using S100A9, CCL5 and blood biomarkers for nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Lu","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenze","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qizhuo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangkang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huidan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"92518_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"92518_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su, Z. Y., Siak, P. Y., Lwin, Y. Y. & Cheah, S. C. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 43, 919\u2013939. https:\/\/doi.org\/10.1007\/s10555-024-10176-9 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"92518_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/cas.14381","volume":"111","author":"T Lu","year":"2020","unstructured":"Lu, T. et al. Circulating Epstein-Barr virus MicroRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Sci. 111, 1711\u20131723. https:\/\/doi.org\/10.1111\/cas.14381 (2020).","journal-title":"Cancer Sci."},{"key":"92518_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/cac2.12100","volume":"40","author":"R Tan","year":"2020","unstructured":"Tan, R. et al. Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma. Cancer Commun. (London England). 40, 564\u2013585. https:\/\/doi.org\/10.1002\/cac2.12100 (2020).","journal-title":"Cancer Commun. (London England)"},{"key":"92518_CR5","doi-asserted-by":"publisher","unstructured":"AbuSalah, M. A. H. et al. Recent advances in diagnostic approaches for Epstein-Barr virus. Pathogens 9 https:\/\/doi.org\/10.3390\/pathogens9030226 (2020).","DOI":"10.3390\/pathogens9030226"},{"key":"92518_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4020-6191-2_5","volume":"45","author":"CW Heizmann","year":"2007","unstructured":"Heizmann, C. W., Ackermann, G. E. & Galichet, A. Pathologies involving the S100 proteins and RAGE. Subcell. Biochem. 45, 93\u2013138. https:\/\/doi.org\/10.1007\/978-1-4020-6191-2_5 (2007).","journal-title":"Subcell. Biochem."},{"key":"92518_CR7","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","volume":"72","author":"C Gebhardt","year":"2006","unstructured":"Gebhardt, C., Nemeth, J., Angel, P. & Hess, J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622\u20131631. https:\/\/doi.org\/10.1016\/j.bcp.2006.05.017 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"92518_CR8","doi-asserted-by":"publisher","first-page":"188891","DOI":"10.1016\/j.bbcan.2023.188891","volume":"1878","author":"Y Chen","year":"2023","unstructured":"Chen, Y., Ouyang, Y., Li, Z., Wang, X. & Ma, J. S100A8 and S100A9 in Cancer. Biochim. Biophys. Acta Rev. Cancer. 1878, 188891. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188891 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"92518_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jcb.22028","volume":"106","author":"MX Li","year":"2009","unstructured":"Li, M. X. et al. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue. J. Cell. Biochem. 106, 570\u2013579. https:\/\/doi.org\/10.1002\/jcb.22028 (2009).","journal-title":"J. Cell. Biochem."},{"key":"92518_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cyto.2013.06.313","volume":"64","author":"T Kato","year":"2013","unstructured":"Kato, T. et al. CCR1\/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2\/9 and by activating ERK and Rac signaling. Cytokine 64, 251\u2013257. https:\/\/doi.org\/10.1016\/j.cyto.2013.06.313 (2013).","journal-title":"Cytokine"},{"key":"92518_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature06188","volume":"449","author":"AE Karnoub","year":"2007","unstructured":"Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557\u2013563. https:\/\/doi.org\/10.1038\/nature06188 (2007).","journal-title":"Nature"},{"key":"92518_CR12","doi-asserted-by":"publisher","unstructured":"Bottcher, J. P. et al. NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control. Cell 172, 1022\u20131037 e1014, (2018). https:\/\/doi.org\/10.1016\/j.cell.2018.01.004","DOI":"10.1016\/j.cell.2018.01.004"},{"key":"92518_CR13","doi-asserted-by":"publisher","unstructured":"Huffman, A. P., Lin, J. H., Kim, S. I., Byrne, K. T. & Vonderheide, R. H. CCL5 mediates CD40-driven CD4\u2009+\u2009T cell tumor infiltration and immunity. JCI Insight. 5 https:\/\/doi.org\/10.1172\/jci.insight.137263 (2020).","DOI":"10.1172\/jci.insight.137263"},{"key":"92518_CR14","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1158\/0008-5472.CAN-11-3917","volume":"72","author":"M Velasco-Velazquez","year":"2012","unstructured":"Velasco-Velazquez, M. et al. CCR5 antagonist blocks metastasis of basal breast cancer cells. Cancer Res. 72, 3839\u20133850. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3917 (2012).","journal-title":"Cancer Res."},{"key":"92518_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1158\/0008-5472.CAN-17-0915","volume":"78","author":"X Jiao","year":"2018","unstructured":"Jiao, X. et al. CCR5 governs DNA damage repair and breast Cancer stem cell expansion. Cancer Res. 78, 1657\u20131671. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0915 (2018).","journal-title":"Cancer Res."},{"key":"92518_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cyto.2018.04.027","volume":"110","author":"YC Wu","year":"2018","unstructured":"Wu, Y. C. et al. Autocrine CCL5 promotes tumor progression in esophageal squamous cell carcinoma in vitro. Cytokine 110, 94\u2013103. https:\/\/doi.org\/10.1016\/j.cyto.2018.04.027 (2018).","journal-title":"Cytokine"},{"key":"92518_CR17","doi-asserted-by":"publisher","unstructured":"Aldinucci, D. & Casagrande, N. Inhibition of the CCL5\/CCR5 Axis against the progression of gastric Cancer. Int. J. Mol. Sci. 19 https:\/\/doi.org\/10.3390\/ijms19051477 (2018).","DOI":"10.3390\/ijms19051477"},{"key":"92518_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccell.2016.03.005","volume":"29","author":"N Halama","year":"2016","unstructured":"Halama, N. et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by Anti-CCR5 therapy in cancer patients. Cancer Cell. 29, 587\u2013601. https:\/\/doi.org\/10.1016\/j.ccell.2016.03.005 (2016).","journal-title":"Cancer Cell."},{"key":"92518_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s12032-015-0607-x","volume":"32","author":"A Pervaiz","year":"2015","unstructured":"Pervaiz, A., Ansari, S., Berger, M. R. & Adwan, H. CCR5 blockage by Maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells. Med. Oncol. 32, 158. https:\/\/doi.org\/10.1007\/s12032-015-0607-x (2015).","journal-title":"Med. Oncol."},{"key":"92518_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pros.20306","volume":"66","author":"GG Vaday","year":"2006","unstructured":"Vaday, G. G., Peehl, D. M., Kadam, P. A. & Lawrence, D. M. Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66, 124\u2013134. https:\/\/doi.org\/10.1002\/pros.20306 (2006).","journal-title":"Prostate"},{"key":"92518_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41598-018-19643-0","volume":"8","author":"SK Singh","year":"2018","unstructured":"Singh, S. K. et al. CCR5\/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci. Rep. 8, 1323. https:\/\/doi.org\/10.1038\/s41598-018-19643-0 (2018).","journal-title":"Sci. Rep."},{"key":"92518_CR22","first-page":"869","volume":"7","author":"J Zi","year":"2017","unstructured":"Zi, J. et al. Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor Maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells. Am. J. cancer Res. 7, 869\u2013880 (2017).","journal-title":"Am. J. cancer Res."},{"key":"92518_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12874-016-0209-0","volume":"16","author":"R Pajouheshnia","year":"2016","unstructured":"Pajouheshnia, R., Pestman, W. R., Teerenstra, S. & Groenwold, R. H. A computational approach to compare regression modelling strategies in prediction research. BMC Med. Res. Methodol. 16, 107. https:\/\/doi.org\/10.1186\/s12874-016-0209-0 (2016).","journal-title":"BMC Med. Res. Methodol."},{"key":"92518_CR24","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.7150\/jca.31267","volume":"10","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. The significance of serum S100A9 and TNC levels as biomarkers in colorectal Cancer. J. Cancer. 10, 5315\u20135323. https:\/\/doi.org\/10.7150\/jca.31267 (2019).","journal-title":"J. Cancer"},{"key":"92518_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/00365513.2019.1704050","volume":"80","author":"P Moravkova","year":"2020","unstructured":"Moravkova, P., Kohoutova, D., Vavrova, J., Bures, J. & Serum S100A6, S100A8, S100A9 and S100A11 proteins in colorectal neoplasia: results of a single centre prospective study. Scand. J. Clin. Lab. Invest. 80, 173\u2013178. https:\/\/doi.org\/10.1080\/00365513.2019.1704050 (2020).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"92518_CR26","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10059-013-2269-x","volume":"35","author":"CH Kwon","year":"2013","unstructured":"Kwon, C. H., Moon, H. J., Park, H. J., Choi, J. H. & Park, D. Y. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-kappaB activation in gastric cancer cells. Mol. Cells. 35, 226\u2013234. https:\/\/doi.org\/10.1007\/s10059-013-2269-x (2013).","journal-title":"Mol. Cells"},{"key":"92518_CR27","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1002\/jcp.25724","volume":"232","author":"Y Nishikawa","year":"2017","unstructured":"Nishikawa, Y. et al. Calprotectin induces IL-6 and MCP-1 production via Toll-Like receptor 4 signaling in human gingival fibroblasts. J. Cell. Physiol. 232, 1862\u20131871. https:\/\/doi.org\/10.1002\/jcp.25724 (2017).","journal-title":"J. Cell. Physiol."},{"key":"92518_CR28","doi-asserted-by":"publisher","first-page":"31317","DOI":"10.1074\/jbc.M703951200","volume":"282","author":"E Leclerc","year":"2007","unstructured":"Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W. & Galichet, A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) Immunoglobulin domains. J. Biol. Chem. 282, 31317\u201331331. https:\/\/doi.org\/10.1074\/jbc.M703951200 (2007).","journal-title":"J. Biol. Chem."},{"key":"92518_CR29","doi-asserted-by":"publisher","first-page":"e72138","DOI":"10.1371\/journal.pone.0072138","volume":"8","author":"JC Simard","year":"2013","unstructured":"Simard, J. C. et al. S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-kappaB(1). PLoS One. 8, e72138. https:\/\/doi.org\/10.1371\/journal.pone.0072138 (2013).","journal-title":"PLoS One"},{"key":"92518_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/CIRCRESAHA.107.167544","volume":"102","author":"JH Boyd","year":"2008","unstructured":"Boyd, J. H., Kan, B., Roberts, H., Wang, Y. & Walley, K. R. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ. Res. 102, 1239\u20131246. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.167544 (2008).","journal-title":"Circ. Res."},{"key":"92518_CR31","doi-asserted-by":"publisher","first-page":"37576","DOI":"10.1038\/srep37576","volume":"6","author":"Q Guo","year":"2016","unstructured":"Guo, Q. et al. Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy. Sci. Rep. 6, 37576. https:\/\/doi.org\/10.1038\/srep37576 (2016).","journal-title":"Sci. Rep."},{"key":"92518_CR32","doi-asserted-by":"publisher","unstructured":"Wen, L. et al. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K\/Akt Signaling Pathway. Biomed Res Int 9917365, (2021). https:\/\/doi.org\/10.1155\/2021\/9917365 (2021).","DOI":"10.1155\/2021\/9917365"},{"key":"92518_CR33","doi-asserted-by":"publisher","unstructured":"Aldinucci, D., Borghese, C. & Casagrande, N. The CCL5\/CCR5 Axis in Cancer progression. Cancers (Basel). 12 https:\/\/doi.org\/10.3390\/cancers12071765 (2020).","DOI":"10.3390\/cancers12071765"},{"key":"92518_CR34","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/1535-7163.MCT-12-0895","volume":"12","author":"X Wang","year":"2013","unstructured":"Wang, X. et al. Endothelial cells enhance prostate cancer metastasis via IL-6\u2013>androgen receptor\u2013>TGF-beta\u2013>MMP-9 signals. Mol. Cancer Ther. 12, 1026\u20131037. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0895 (2013).","journal-title":"Mol. Cancer Ther."},{"key":"92518_CR35","doi-asserted-by":"publisher","first-page":"e94473","DOI":"10.1371\/journal.pone.0094473","volume":"9","author":"XJ Du","year":"2014","unstructured":"Du, X. J. et al. The pretreatment albumin to Globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLoS One. 9, e94473. https:\/\/doi.org\/10.1371\/journal.pone.0094473 (2014).","journal-title":"PLoS One"},{"key":"92518_CR36","first-page":"767","volume":"18","author":"A Alacacioglu","year":"2013","unstructured":"Alacacioglu, A., Tarhan, O., Alacacioglu, I., Dirican, A. & Yilmaz, U. Depression and anxiety in cancer patients and their relatives. J. BUON. 18, 767\u2013774 (2013).","journal-title":"J. BUON"},{"key":"92518_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12032-014-0238-7","volume":"31","author":"X Qu","year":"2014","unstructured":"Qu, X. et al. High percentage of alpha1-globulin in serum protein is associated with unfavorable prognosis in non-small cell lung cancer. Med. Oncol. 31, 238. https:\/\/doi.org\/10.1007\/s12032-014-0238-7 (2014).","journal-title":"Med. Oncol."},{"key":"92518_CR38","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1016\/j.clnu.2021.03.031","volume":"40","author":"A Weimann","year":"2021","unstructured":"Weimann, A. et al. ESPEN practical guideline: clinical nutrition in surgery. Clin. Nutr. 40, 4745\u20134761. https:\/\/doi.org\/10.1016\/j.clnu.2021.03.031 (2021).","journal-title":"Clin. Nutr."},{"key":"92518_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2147\/CMAR.S402572","volume":"15","author":"J Wu","year":"2023","unstructured":"Wu, J., Luo, H., Wang, K. & Yi, B. Development and validation of a novel diagnostic nomogram model using serum oxidative stress markers and AURKA for prediction of nasopharyngeal carcinoma. Cancer Manag Res. 15, 1053\u20131062. https:\/\/doi.org\/10.2147\/CMAR.S402572 (2023).","journal-title":"Cancer Manag Res."},{"key":"92518_CR40","doi-asserted-by":"publisher","first-page":"e0284103","DOI":"10.1371\/journal.pone.0284103","volume":"18","author":"AA Huang","year":"2023","unstructured":"Huang, A. A. & Huang, S. Y. Use of machine learning to identify risk factors for coronary artery disease. PLoS One. 18, e0284103. https:\/\/doi.org\/10.1371\/journal.pone.0284103 (2023).","journal-title":"PLoS One"},{"key":"92518_CR41","doi-asserted-by":"publisher","first-page":"e0281922","DOI":"10.1371\/journal.pone.0281922","volume":"18","author":"AA Huang","year":"2023","unstructured":"Huang, A. A. & Huang, S. Y. Increasing transparency in machine learning through bootstrap simulation and shapely additive explanations. PLoS One. 18, e0281922. https:\/\/doi.org\/10.1371\/journal.pone.0281922 (2023).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92518-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T14:24:58Z","timestamp":1749824698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92518"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92518-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article Lu Long and Ya Tao were omitted as equally contributing authors.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Ethics Committee of Xiangya Hospital of Central South University (No. 2024101312), and carried out in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"7502"}}